# An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure

> **NCT00813202** · PHASE3 · COMPLETED · sponsor: **Xian-Janssen Pharmaceutical Ltd.** · enrollment: 41 (actual)

## Conditions studied

- Heart Decompensation
- Congestive Heart Failure

## Interventions

- **DRUG:** Nesiritide

## Key facts

- **NCT ID:** NCT00813202
- **Lead sponsor:** Xian-Janssen Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-06
- **Final completion:** 2007-06
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2014-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813202

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813202, "An Open-label, One-arm, Study to Evaluate the Hemodynamic Changes and Safety of Nesiritide for Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00813202. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*